MARVEL GOLD LIMITED — Director's Dealing 2021

Nov 24, 2021

2 5 November 2021

Company Announcements Platform ASX Limited 20 Bridge Street SYDNEY NSW 2000

Dear Sir / Madam

Appendix 3Y – Change of Director’s Interest Notice – Mr Stephen Dennis, Mr Andrew Pardey, Mr Phil Hoskins and Mr Chris van Wijk

Please find attached Appendices 3Y with respect to a change in the holdings of Marvel Gold Limited securities for the abovementioned directors. The issue of unquoted options that are the subject of the Appendices 3Y was approved by shareholders at the Annual General Meeting held on 24 November 2021.

Yours faithfully

==> picture [56 x 25] intentionally omitted <==

Stuart McKenzie Company Secretary Marvel Gold Limited

This announcement has been authorised for release by the Company Secretary.

==> picture [596 x 82] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity:	MARVEL GOLDLIMITED
ABN:	77 610 319 769

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Stephen Dennis
Date of last notice	21 August 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Mr Stephen Bruce Dennis & Mrs Alison Jill Dennis
Date of change	25 November 2021
No. of securities held prior to change	Direct • 400,000 Shares Indirect • 3,647,598 Shares • 1,150,000 Unquoted Options, exercisable at $0.035, expiry 29 July 2024 • 575,000 Unquoted Options, exercisable at $0.06, expiry 29 July 2024 • 575,000 Unquoted Options, exercisable at $0.10, expiry 29 July 2024
Class	Unquoted Options
Number acquired	Indirect • 3,000,000 Unquoted Options, exercisable at $0.065, expiry 25 November 2024
Number disposed	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$127,560 (Black & Scholes valuation – see Notice of Meeting of 27 October 2021 for details on the valuation)
No. of securities held after change	Indirect • 4,047,598 Shares • 1,150,000 Unquoted Options, exercisable at $0.035, expiry 29 July 2024 • 575,000 Unquoted Options, exercisable at $0.06, expiry 29 July 2024 • 575,000 Unquoted Options, exercisable at $0.10, expiry 29 July 2024 • 3,000,000 Unquoted Options, exercisable at $0.065, expiry 25 November 2024
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of unquoted options as approved by shareholders at the Annual General Meeting held on 24 November 2021.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 301] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
----- End of picture text -----

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity:	MARVEL GOLDLIMITED
ABN:	77 610 319 769

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Andrew Pardey
Date of last notice	21 August 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	25 November 2021
No. of securities held prior to change	2,000,000 Shares 2,250,000 Unquoted Options, exercisable at $0.035, expiry 29 July 2024 1,125,000 Unquoted Options, exercisable at $0.06, expiry 29 July 2024 1,125,000 Unquoted Options, exercisable at $0.10, expiry 29 July 2024
Class	Unquoted Options
Number acquired	3,000,000 Unquoted Options, exercisable at $0.065, expiry 25 November 2024
Number disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$127,560 (Black & Scholes valuation – see Notice of Meeting of 27 October 2021 for details on the valuation)

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	2,000,000 Shares 2,250,000 Unquoted Options, exercisable at $0.035, expiry 29 July 2024 1,125,000 Unquoted Options, exercisable at $0.06, expiry 29 July 2024 1,125,000 Unquoted Options, exercisable at $0.10, expiry 29 July 2024 3,000,000 Unquoted Options, exercisable at $0.065, expiry 25 November 2024
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of unquoted options as approved by shareholders at the Annual General Meeting held on 24 November 2021.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If prior written clearance was provided, on what date was this provided?

N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: MARVEL GOLD LIMITED

ABN: 77 610 319 769

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Phil Hoskins
Date of last notice	28 January 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Phil Hoskins Pty Ltd S/F> Self-managed superannuation fund
Date of change	24 November 2021
No. of securities held prior to change	Direct  2,999,209 Shares  5,125,000 Unquoted Options exercisable at $0.035, expiry 29 July 2024  2,562,500 Unquoted Options exercisable at $0.06, expiry 29 July 2024  2,562,500 Unquoted Options exercisable at $0.10, expiry 29 July 2024 Indirect  4,462,119 Shares
Class	Shares Options
Number acquired	425,000 Shares 5,000,000 Options
Number disposed

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Shares: $30,685.20 (0.0722 per Share) Unquoted Options: Refer to Notice of Meeting dated 27/10/21 for information on the valuation of the Options
No. of securities held after change	 7,286,328 Shares Indirect performance criteria 2026, vesting 1 July 2024 subject to exercise price, expiring 24 November  2,500,000 Unquoted Options with a nil performance criteria 2024, vesting 1 July 2022 subject to exercise price, expiring 24 November  2,500,000 Unquoted Options with a nil at $0.10, expiry 29 July 2024  2,562,500 Unquoted Options exercisable at $0.06, expiry 29 July 2024  2,562,500 Unquoted Options exercisable at $0.035, expiry 29 July 2024  5,125,000 Unquoted Options exercisable  600,000 Shares Direct
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	 On-market purchase of Shares  Issue of options as approved by shareholders at the AGM held on 24 November 2021

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: MARVEL GOLD LIMITED ABN: 77 610 319 769

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Chris van Wijk
Date of last notice	28 January 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	CHRIS VAN WIJK Family trust
Date of change	25 November 2021
No. of securities held prior to change	412,500 Shares 4,375,000 Unquoted Options, exercisable at $0.035, expiry 29 July 2024 2,187,500 Unquoted Options, exercisable at $0.06, expiry 29 July 2024 2,187,500 Unquoted Options, exercisable at $0.10, expiry 29 July 2024
Class	Unquoted Options
Number acquired	3,692,308 Unquoted Options
Number disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Refer to Notice of Meeting dated 27/10/21 for information on the valuation of the Options

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change

Direct  412,500 Shares  4,375,000 Unquoted Options, exercisable at $0.035, expiry 29 July 2024  2,187,500 Unquoted Options, exercisable at $0.06, expiry 29 July 2024  2,187,500 Unquoted Options, exercisable at $0.10, expiry 29 July 2024 Indirect  1,846,154 Unquoted Options with a nil exercise price, expiring 24 November 2024, vesting 1 July 2022 subject to performance criteria  1,846,154 Unquoted Options with a nil exercise price, expiring 24 November 2026, vesting 1 July 2024 subject to performance criteria

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back

Issue of options as approved by shareholders at the AGM held on 24 November 2021

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3